(Q43631510)

25 November 2017

title

A comparison of the effects on saliva output of oxybutynin chloride and tolterodine tartrate (English)

1 reference

25 November 2017

1 reference

Chancellor MB

1

1 reference

25 November 2017

Appell RA

series ordinal

2

1 reference

25 November 2017

Sathyan G

series ordinal

3

1 reference

25 November 2017

Gupta SK

series ordinal

4

1 reference

25 November 2017

publication date

1 May 2001

1 reference

25 November 2017

published in

Clinical Therapeutics

1 reference

25 November 2017

volume

23

1 reference

25 November 2017

issue

5

1 reference

25 November 2017

page(s)

753-760

1 reference

A review of the quality-of-life aspects of urinary urge incontinence

25 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980024-2

7 January 2021

Oxybutynin. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic use in detrusor instability.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980024-2

7 January 2021

Evaluation of a new once-daily formulation of oxbutynin for the treatment of urinary urge incontinence. Ditropan XL Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980024-2

7 January 2021

Tolterodine, a new antimuscarinic agent: as effective but better tolerated than oxybutynin in patients with an overactive bladder

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980024-2

7 January 2021

Effect of OROS controlled-release delivery on the pharmacokinetics and pharmacodynamics of oxybutynin chloride

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980024-2

7 January 2021

Dry mouth with conventional and controlled-release oxybutynin in urinary incontinence. The Ditropan XL Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980024-2

7 January 2021

Clinical implications of the dry mouth. Oral mucosal diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980024-2

7 January 2021

Clinical efficacy and safety of tolterodine in the treatment of overactive bladder: a pooled analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980024-2

7 January 2021

10.1016/S0149-2918(01)80024-2

Identifiers

DOI

1 reference

25 November 2017

1 reference